Company profile
Ventana Biotech, Inc.
OTC: VNTA · Financial Services · Shell Companies
PublicHQ Denver, Reports USD
#816 of 1,012 Financial Services companies by revenuetop-decile growth
EA Score
——FH 54DQ —GM —SS 22
v0.1 · 35/100 weight · pillars only
↑ return on assets, revenue growth (YoY) · ↓ workforce scale, market scale
Methodology →Revenue TTM
$114.6k
Rev growth YoY (TTM)
+178.7%
Net income (FY)
$86.1k
Employees
1
as of 2026-07-14
Market cap
$90.9k
as of 2026-07-14
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$114.6k$114.6k2025
Net income$86.1k$86.1k2025
Operating income$100.8k$100.8k2025
Total assets$62.0k$62.0k2024
Liabilities$114.3k$114.3k2024
Equity-$52.3k-$52.3k2024
Revenue trend
FY2007 – FY2025 · USD
FY07
FY08
FY18
FY19
FY21
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Ventana Biotech, Inc.’s revenue?
Ventana Biotech, Inc. booked $114.6k in FY2025 revenue, growing 177% year over year — faster than 93% of Financial Services companies we track, at a 75.2% net margin.
Peers · Financial Services
The NFT Marketplace, Inc.——Metavesco, Inc.——Vemanti Group, Inc.——FCCC, Inc.——Global Asset Management Group I18DAxis Technologies Group, Inc.——Key facts
CEOJanne Christensen
SectorFinancial Services
IndustryShell Companies
HeadquartersDenver, null
ExchangeOTC: VNTA
Employees1
IPO date2009-09-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.